ArticleScientific reports2015

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML.

Shuang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.